Competing interests Nik Krajnc: has participated in meetings sponsored by, received speaker honoraria or travel funding from BMS/Celgene, Janssen-Cilag, Merck, Novartis, Roche and Sanofi-Genzyme and held a grant for a Multiple Sclerosis Clinical Training Fellowship Programme from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Factors that predict better outcomes include higher starting BMI, adherence to dietary recommendations, regular physical activity, proper dose titration, and consistent weekly administration
this should be considered by clinicians in any trial or supervised setting, in line with NICE guideline NG28 (Type 2 diabetes in adults)
Patient-Specific Dosing: Adjust volumes and medication strength for pediatric, geriatric, renal, or cardiac patients as indicated
Even if you eat all the right foods that are rich in B12, that doesnt mean your body will be able to retain the vitamin
In rats, GCLC has a Km for glutamate that is about 10-fold higher, which is higher than the cellular glutamate concentration in most tissues